Genenta Science SpA ADR
Price & Volume
Stats
See more52W Range | $2.20-$7.28 |
Market Cap | $96.9M |
Shares Short | 1,422 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.52 |
News
See moreYahoo Finance • last year
Genenta to Present at Upcoming Scientific and Investor Conferences
Yahoo Finance • last year
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
Yahoo Finance • 2 years ago
Genenta to Provide Update on Lead Product Temferon™
Yahoo Finance • 2 years ago
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
About
CEO | Mr. Pierluigi Paracchi |
Address | Via Olgettina No. 58, Milan, MI, Italy, 20132 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
